Risultati di ricerca
Dr. Momper directs the Translational Pharmacology and Bioanalysis Laboratory concentrated on novel mass spectrometry-based analytical methods, in vitro ADME assays, and pre-clinical and clinical pharmacokinetic studies.
A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with Early Alzheimer's Disease. medRxiv. 2024 Mar 22.
- 9500 Gilman Drive # La Jolla CA 92093
- Vc-health Sciences-schools
Jeremiah D. Momper, PharmD, PhD, is an Associate Professor at UC San Diego’s Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Momper’s research focuses on the application of quantitative pharmacology approaches to optimize the development and clinical use of drugs.
View Jeremiah Momper’s profile on LinkedIn, the world’s largest professional community. Jeremiah has 6 jobs listed on their profile.
- 500+
- 734
- UC San Diego
- Rancho Santa Fe, California, United States
Jeremiah Momper, PharmD, PhD. Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences. University of California, San Diego The Momper lab works on quantitative determination of drugs and metabolites in human milk using mass spectrometry as well as on pharmacokinetic modeling and simulation to predict drug ...
14 ago 2020 · Pharmacokinetic boosting of antiretroviral (ARV) therapies with either ritonavir or cobicistat is used to achieve target drug exposure, lower pill burden, and provide simplified dosing schedules.
Jeremiah D. Momper's 86 research works with 1,286 citations and 6,880 reads, including: Variable Delta-9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics After Cannabis Smoking in...
